Education
About Us
Working with TipRanks
Follow Us
Quest Diagnostics (DGX)
NYSE:DGX
Total Valuation
Quest Diagnostics has a market cap or net worth of $23.01B. The enterprise value is $29.36B.
Market Cap$23.01B
Enterprise Value$29.36B
Share Statistics
Quest Diagnostics has 111,242,360 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding111,242,360
Owned by Insiders0.42%
Owned by Institutions11.90%
Financial Efficiency
Quest Diagnostics’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 8.43%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)8.43%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee200.64K
Profits Per Employee19.02K
Employee Count55,000
Asset Turnover0.68
Inventory Turnover39.75
Valuation Ratios
The current PE Ratio of Quest Diagnostics is 23.6. Quest Diagnostics’s PEG ratio is 1.42.
PE Ratio23.6
PS Ratio1.75
PB Ratio2.69
Price to Fair Value2.69
Price to FCF14.17
Price to Operating Cash Flow12.09
PEG Ratio1.42
Income Statement
In the last 12 months, Quest Diagnostics had revenue of 11.04B and earned 992.00M in profits. Earnings per share was 8.87.
Revenue11.04B
Gross Profit3.52B
Operating Income1.60B
Pretax Income1.36B
Net Income992.00M
EBITDA2.15B
Earnings Per Share (EPS)8.87
Cash Flow
In the last 12 months, operating cash flow was 1.89B and capital expenditures -527.00M, giving a free cash flow of 1.36B billion.
Operating Cash Flow1.89B
Free Cash Flow1.36B
Free Cash Flow per Share12.22
Dividends & Yields
Quest Diagnostics pays an annual dividend of $0.8, resulting in a dividend yield of 1.8%
Dividend Per Share$0.8
Dividend Yield1.8%
Payout Ratio32.61%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.17
52-Week Price Change21.87%
50-Day Moving Average183.05
200-Day Moving Average178.75
Relative Strength Index (RSI)73.31
Average Volume (3m)1.13M
Important Dates
Quest Diagnostics upcoming earnings date is Apr 28, 2026, Before Open (Confirmed).
Last Earnings DateFeb 10, 2026
Next Earnings DateApr 28, 2026
Ex-Dividend Date―
Financial Position
Quest Diagnostics as a current ratio of 1.04, with Debt / Equity ratio of 96.50%
Current Ratio1.04
Quick Ratio0.96
Debt to Market Cap0.33
Net Debt to EBITDA3.02
Interest Coverage Ratio6.07
Taxes
In the past 12 months, Quest Diagnostics has paid 314.00M in taxes.
Income Tax314.00M
Effective Tax Rate0.23
Enterprise Valuation
Quest Diagnostics EV to EBITDA ratio is 11.97, with an EV/FCF ratio of 18.96.
EV to Sales2.33
EV to EBITDA11.97
EV to Free Cash Flow18.96
EV to Operating Cash Flow13.66
Balance Sheet
Quest Diagnostics has $420.00M in cash and marketable securities with $6.92B in debt, giving a net cash position of -$6.50B billion.
Cash & Marketable Securities$420.00M
Total Debt$6.92B
Net Cash-$6.50B
Net Cash Per Share-$58.42
Tangible Book Value Per Share-$29.68
Margins
Gross margin is 33.25%, with operating margin of 14.53%, and net profit margin of 8.99%.
Gross Margin33.25%
Operating Margin14.53%
Pretax Margin12.32%
Net Profit Margin8.99%
EBITDA Margin19.50%
EBIT Margin14.34%
Analyst Forecast
The average price target for Quest Diagnostics is $220.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$220.00
Price Target Upside6.35% Upside
Analyst ConsensusModerate Buy
Analyst Count11
Revenue Growth Forecast13.74%
EPS Growth Forecast14.87%